Parkemed
Parkemed Brand names, Parkemed Analogs
Parkemed Brand Names Mixture
- No information avaliable
Parkemed Chemical_Formula
C15H15NO2
Parkemed RX_link
http://www.rxlist.com/cgi/generic3/mefenamic.htm
Parkemed fda sheet
Parkemed msds (material safety sheet)
Parkemed Synthesis Reference
No information avaliable
Parkemed Molecular Weight
241.285 g/mol
Parkemed Melting Point
230-231 oC
Parkemed H2O Solubility
20 mg/L
Parkemed State
Solid
Parkemed LogP
4.041
Parkemed Dosage Forms
Bolus; Capsule; Capsule (enteric-coated); Drops; Liquid; Lotion; Powder; Powder for solution; Shampoo; Soap bar; Solution; Stick; Syrup; Tablet; Tablet (extended-release)
Parkemed Indication
For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.
Parkemed Pharmacology
Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase.
Parkemed Absorption
Mefenamic acid is rapidly absorbed after oral administration.
Parkemed side effects and Toxicity
Oral, rat LD50: 740 mg/kg. Symptoms of overdose may include severe stomach pain, coffee ground-like vomit, dark stool, ringing in the ears, change in amount of urine, unusually fast or slow heartbeat, muscle weakness, slow or shallow breathing, confusion, severe headache or loss of consciousness.
Parkemed Patient Information
Parkemed Organisms Affected
Humans and other mammals
